Dr. Jeremy I. Schwartz is an Associate Professor at Yale School of Medicine (Department of Medicine) and Yale School of Public Health (Department of Chronic Disease Epidemiology). He specializes in non-communicable diseases (NCDs), global health, and digital health interventions. As Firm Chief of Yale Primary Care Residency Program and Director of the Faculty Network Program at the Yale Institute for Global Health, he leads initiatives to improve healthcare delivery in low-resource settings. He co-founded the Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), collaborating with Ugandan institutions to address fragmented NCD care. His research focuses on hypertension, diabetes, and heart failure management in Uganda, leveraging mobile health (mHealth) tools. He also directs the 'Topics in Global Medicine' course at Yale, training future healthcare leaders in global health challenges. Education: MD from University of Rochester School of Medicine & Dentistry (2006), BS from Cornell University (2000). Honors include the Doran J. Stevens Prize (2006), Gold Humanism Honor Society (2006), and Alpha Omega Alpha (2005). Key roles: Medical Director of the Eastern Caribbean Health Outcomes Research Network (ECHORN), Co-Director of UINCD, and affiliated faculty at the Yale Institute for Global Health and Center for Interdisciplinary Research on AIDS. His work emphasizes interdisciplinary collaboration, with a focus on Africa and the Caribbean. Research emphasizes integrated care models, digital health innovations, and policy advocacy for NCDs. Recent projects include adapting mobile health applications for heart failure patients and evaluating cost barriers to essential medicines in Uganda.
Patrick T. Dowling, M.D., M.P.H., is the Kaiser Permanente Endowed Professor of Community Medicine and Chair of the UCLA Department of Family Medicine. He holds dual degrees from the Medical College of Ohio (1974) and the University of Michigan School of Public Health. Dr. Dowling's career spans over four decades in family medicine, residency training, and health policy advocacy, with a focus on underserved populations. He has directed residency programs at Cook County Hospital, Brown University, and Harbor-UCLA Medical Center before leading UCLA's Family Medicine department since 1998. His research emphasizes health policy, chronic disease management, cross-cultural medicine, and integrating substance abuse treatment into primary care. He co-founded UCLA's IMG pathway program to train bilingual (English-Spanish) international medical graduates for underserved areas. Dr. Dowling has advised the National Health Service Corps and LA County Public Health Commission, and currently serves on Drew University's Board of Trustees. Publications highlight systemic barriers to healthcare access, physician practice location determinants, opioid epidemic responses, and community-based participatory research. His work bridges medical education innovation with socioeconomic health equity, reflecting lifelong commitment to universal healthcare access inspired by his early work with Cesar Chavez's United Farm Workers Clinics.
Dr. Philippa Carter is University Assistant Professor in the History of Medicine and Health before 1800 at the University of Cambridge's Department of History and Philosophy of Science. She serves as an Affiliated Lecturer in the Faculty of History and is a Fellow and Director of Studies at Sidney Sussex College. Additionally, she manages the MPhil in Health, Medicine and Society program. Her educational background focuses on early modern European history with specialization in medical and intellectual history. Her research spans a wide range of interests including: Early understandings of mental and physical illness Bodies and embodiment in historical contexts Mind/body relations in premodern thought Disability and visible difference Disease categorization and diagnosis across historical periods Boundaries between natural philosophy, magic, and religion Sciences of the psyche Dr. Carter's scholarly work examines premodern Aristotelian understandings of 'nature,' particularly in the processes of 'generation' and 'corruption.' Her research bridges cultural history, medical history, gender studies, and the history of science, with particular attention to how historical societies conceptualized bodily experience and mental states. She has published significant work on childbirth and madness, gender and witchcraft, and is currently completing a monograph on madness, brain disease, and the soul in early modern England. Her recent publications demonstrate a consistent focus on the intersection of gender, medicine, and social history in early modern contexts. The articles reveal trends toward examining marginalized historical experiences, particularly women's health and mental states, while connecting historical medical concepts to contemporary understandings. Among her notable scholarly contributions: 'Childbirth, "Madness", and Bodies in History' (History Workshop Journal, 2021) 'Work, Gender and Witchcraft in Early Modern England' (Gender & History, 2023) "Madness Embodied" (forthcoming in The Bloomsbury Cultural History of Madness) Dr. Carter teaches on Early Science and Medicine at the Department of HPS, Part I History Tripos Outline Paper 4 ('Early Modern Britain'), and Part II, Paper 11 ('Early Medicine'). She serves as Associate Editor for the digital humanities project 'Reading Early Medicine' and is actively involved with Cambridge Reproduction research initiatives. Her work contributes significantly to interdisciplinary approaches to historical medical understanding, connecting past and present perspectives on reproductive health, mental illness, and bodily experience.
Dr. Jeannine Baumgartner is a Lecturer in the Department of Nutritional Sciences at King's College London and an Extraordinary Associate Professor at North-West University, South Africa. She holds an MSc and PhD in Human Nutrition from ETH Zurich, Switzerland. Key Appointments : Lecturer at King's College London (2022–present), Senior Scientist at ETH Zurich (2018–2022), Associate Professor at North-West University (2018). Research Focus : Optimal early-life nutrition for maternal/child health, iron and omega-3 fatty acid interventions, stable isotope methodologies, HIV-metabolic interactions, and mental health-diet links. Her recent work explores iron absorption dynamics in Thai children, maternal iron status in South Africa, and omega-3 fatty acids in depression. She leads an NIHR-funded project to reassess UK iron reference values. Scientific Leadership : Board Member, International Society for the Study of Fatty Acids and Lipids (ISSFAL) Editorial Board, European Journal of Clinical Nutrition
William John Moss is a Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where he also holds joint appointments in International Health and Molecular Microbiology and Immunology. He serves as Executive Director of the International Vaccine Access Center (IVAC) and Deputy Director at the Johns Hopkins Malaria Research Institute. His work spans multiple centers including the Center for Global Health, Center for Humanitarian Health, and Johns Hopkins Vaccine Initiative. Dr. Moss earned his MD from Columbia University in 1984 and his MPH in 1995. As a pediatrician with subspecialty training in infectious diseases, he has conducted extensive field research across multiple countries including Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India. His research focuses on the epidemiology and control of childhood infections in resource-poor settings, with particular emphasis on measles-HIV interactions, malaria transmission in southern Africa, serosurveillance for immunization programs, and care of HIV-infected children in rural Zambia. His recent work (2024-2025) demonstrates continued focus on measles epidemiology, malaria transmission dynamics, and vaccine implementation research, with numerous publications examining immunity gaps, human mobility patterns, and malaria vector biology in African settings. Scientific Awards: Wyeth-Lederle Vaccines and Pediatrics Young Investigator Award in Vaccine Development (1999-2001) Gustave J. Martin Innovative Research Fund Fellow (2001) Advising, Mentoring and Teaching Recognition Award (2007-2008) Dr. Moss leads multiple research projects including studies on HIV-infected children's immune reconstitution, malaria transmission dynamics in southern Zambia, and strengthening immunization systems through serosurveillance. His work bridges clinical medicine, epidemiology, and public health policy to address critical challenges in global infectious disease control.
Sharon Rozovsky is a Professor in the Department of Chemistry and Biochemistry at the University of Delaware's College of Arts & Sciences, where she leads research on oxidative stress response mechanisms and protein quality control pathways. Her work bridges biochemistry, chemical biology, and structural biology with direct implications for understanding neurodegenerative diseases and viral pathogenesis. Her academic foundation includes a B.S. from Tel Aviv University (1994) and a Ph.D. from Columbia University (2000), establishing her expertise in protein dynamics and redox biochemistry. These credentials underpin her innovative approaches to studying cellular stress responses. Rozovsky's research program centers on selenoproteins—proteins containing the rare amino acid selenocysteine—and their critical roles in endoplasmic reticulum (ER) stress resolution. She investigates how membrane-bound selenoproteins like Selenoprotein S and K regulate the ER-associated degradation (ERAD) pathway, with recent work revealing their surprising autoproteolytic activity and involvement in SARS-CoV-2 replication. Her lab pioneers chemical tools including expressed protein ligation and advanced 77Se NMR spectroscopy to characterize these systems at molecular resolution. Analysis of her 2021-2025 publications shows dominant themes in selenoprotein structure-function relationships, ER stress mechanisms, and viral interactions, alongside methodological innovations in cryo-EM grid technology and NMR. This body of work demonstrates consistent focus on redox biochemistry with expanding applications in virology and structural biology. No major scientific awards or fellowships were explicitly documented in the available materials, though her research impact is evident through high-impact publications and methodological contributions. She directs the active Rozovsky Research Group, mentoring graduate students and postdoctoral researchers in biochemical and biophysical techniques. Her laboratory operations are supported by competitive funding including an NSF CAREER award (2011) focused on selenoprotein reactivity, reflecting sustained recognition of her innovative research program.
Iona Cheng is a Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF), where she conducts groundbreaking research in cancer epidemiology. She serves as co-Investigator of the SEER Greater Bay Area Cancer Registry and is Principal Investigator of multiple NIH- and foundation-funded projects examining genetics, lifestyle factors, and neighborhood characteristics in relation to cancer risk. Dr. Cheng has developed an extensive research program focused on racial/ethnic differences in cancer risk and leads population-based cancer surveillance studies that document variations in cancer incidence and mortality patterns across diverse racial and ethnic groups. University of California, Davis, BS, 1990–1994, Physiology Yale University, MPH, 1999–2001, Chronic Disease Epidemiology University of Southern California, PhD, 2001–2005, Epidemiology University of California, San Francisco, Postdoc, 2006–2008, Genetic and Molecular Epidemiology Dr. Cheng's research spans multiple disciplines within cancer epidemiology, with particular emphasis on understanding how environmental exposures, genetic factors, and social determinants interact to influence cancer risk and outcomes across different racial and ethnic populations. Her work frequently examines the impact of air pollution, endocrine-disrupting chemicals, and neighborhood characteristics on cancer development and survival. She has made significant contributions to understanding cancer disparities among Asian American, Native Hawaiian, and Pacific Islander populations, bringing attention to the unique cancer risks and outcomes within these understudied groups. Her research often leverages the Multiethnic Cohort Study, one of the largest prospective studies of cancer incidence and mortality across diverse racial/ethnic populations. Analysis of Dr. Cheng's recent publications reveals a consistent focus on environmental and social determinants of cancer risk across multiple organ sites. Her work demonstrates a sophisticated integration of epidemiological methods with environmental exposure assessment, genetic analysis, and health disparities research. Many of her studies examine the intersection of environmental exposures and racial/ethnic disparities in cancer outcomes, particularly regarding breast cancer, lung cancer, and other malignancies. She has published extensively on the impact of air pollution on cancer risk and survival, as well as the effects of endocrine-disrupting chemicals like bisphenol A, parabens, and phthalates. American Association for Cancer Research Scholar-in-Training Award (2007) National Institutes of Health Loan Repayment Award (2007) National Institutes of Health Loan Repayment Renewal Award (2009) American Association for Cancer Research Faculty Scholar Award (2011) National Institutes of Health Loan Repayment Renewal Award (2011) National Institutes of Health Loan Repayment Renewal Award (2013) American Journal of Epidemiology/Society of Epidemiology Research Top 10 manuscripts (2014) Cancer Prevention Institute of California Mentoring Award (2015) American Society of Human Genetics Top poster As Principal Investigator of multiple NIH-funded projects, Dr. Cheng oversees substantial research grants focused on cancer epidemiology and health disparities. Her work often involves large interdisciplinary collaborations with researchers across multiple institutions, including the Multiethnic Cohort Study which follows over 200,000 participants from diverse racial/ethnic backgrounds. She has demonstrated leadership in mentoring junior researchers, particularly those from underrepresented backgrounds in science, as evidenced by her Cancer Prevention Institute of California Mentoring Award. Her research program integrates data from cancer registries, electronic health records, and geospatial information to provide comprehensive insights into cancer patterns and risk factors. Dr. Cheng's research is closely connected to the UCSF Helen Diller Family Comprehensive Cancer Center and leverages collaborations with Lawrence Berkeley National Laboratory, which provides advanced technological resources for cancer research. Her work benefits from access to extensive cohort data, sophisticated exposure assessment methods, and interdisciplinary expertise in genetics, environmental science, and computational biology available through these institutional partnerships. She frequently collaborates with researchers studying the genetic and environmental determinants of cancer across multiple organ systems, contributing to a more comprehensive understanding of cancer etiology and prevention strategies.
Brent Page is an Associate Professor (tenured) in the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) and maintains a research group at the Karolinska Institute , Department of Oncology and Pathology. His dual affiliation underpins a trans-Atlantic program that integrates cutting-edge chemical biology with medicinal chemistry for anti-cancer drug discovery. Education & Training PhD in Chemistry – University of Toronto (2013) HBSc in Chemistry (Honours) – University of British Columbia (2008) CIHR Postdoctoral Fellow – Karolinska Institute, Sweden (2008–2016) Assistant Professor (non-independent) – Karolinska Institute, Department of Oncology-Pathology (2017–2021) Research Focus Dr. Page’s laboratory operates at the interface of medicinal chemistry and chemical biology , aiming to identify and optimize small-molecule inhibitors for proteins previously considered “undruggable.” Core targets include STAT3, CLIC3, NUDT5/15 and SRPK3 . The group employs cellular thermal shift assays , isothermal ligand-induced resolubilization (ILIRA) , and CeTEAM technologies to quantify target engagement and refine structure–activity relationships in physiologically relevant models of breast cancer, triple-negative breast cancer, leukemia and atopic diseases . Funding & Collaborations His program is supported by Canadian Institutes of Health Research (CIHR) and other national and international agencies. Dr. Page actively participates in UBC’s Accelerated Translational Opioid Research Cluster and welcomes interdisciplinary collaborations and undergraduate research involvement. Equity, Diversity & Inclusion Committed to fostering an inclusive environment, Dr. Page mandates EDI training for all lab members and actively encourages participation from equity-deserving groups.
Marita Dale is a Senior Lecturer in the Discipline of Physiotherapy at the University of Sydney and an Early Career Researcher affiliated with the Charles Perkins Centre. She specializes in cardiorespiratory physiotherapy, focusing on exercise interventions for chronic respiratory and cardiac diseases, particularly asbestos-related and dust-related conditions. Her work emphasizes improving accessibility to pulmonary rehabilitation services and leveraging mHealth technologies for patient care. Education: PhD in Physiotherapy (2016, University of Sydney). Her research interests include optimizing pulmonary rehabilitation through mobile health platforms, such as the m-PR™ app, and investigating pediatric burn injury rehabilitation, including orthosis use and scar prevention. She also explores multimorbidity management and simulation-based learning in healthcare education. Recent studies have highlighted her contributions to COPD care protocols, telehealth implementation during the pandemic, and qualitative analyses of patient experiences. Major awards: Sydney School of Health Sciences Teaching Citation (2022), Ashurst Prize for Outstanding Oral Presentation (2015), Helga Pettitt FHS Postgraduate Study Award (2010). Marita supervises Honours, Masters, and PhD students, including Mitchell Taylor on airway clearance in bronchiectasis. Her teaching spans undergraduate and postgraduate programs in cardiopulmonary and musculoskeletal physiotherapy. She collaborates on projects like the Lung Support Service, a nationwide text message program for chronic respiratory patients during the pandemic, and contributed to the commercialization of the Perx-R app for pulmonary rehab. Labs/teams: Active member of the Charles Perkins Centre, focusing on interdisciplinary chronic disease research and healthcare innovation.
Dr. Channakeshava S. Umeshappa is a faculty member in the Department of Microbiology & Immunology and Department of Pediatrics at Dalhousie University, Canada . He holds a PhD in Immunology from the University of Saskatchewan and completed postdoctoral training at the University of Calgary. Education : DVM (Karnataka Veterinary Animal and Fisheries Sciences University, India), MVSc (Indian Veterinary Research Institute, India), PhD (University of Saskatchewan, Canada) Research Interests : Dr. Umeshappa’s program focuses on immunoregulation in chronic diseases , particularly autoimmunity and cancer. His lab employs genetically modified murine models , omics , synthetic biology , flow cytometry , and imaging to develop immunotherapies. His work emphasizes interdisciplinary collaboration with clinicians and scientists. Article Trends : Recent publications highlight nanomedicine applications in autoimmune liver disease (e.g., peptide-MHC nanomedicines, invariant NKT cell reprogramming) and cancer therapy (e.g., laser-responsive nanoparticles, tumor-to-lymph gels). Studies span immuno-informatics , cell signaling , and clinical outcomes analysis.
Dr Thomas Maguire is a Visiting Fellow with the King's Intelligence and Security Group in the Department of War Studies at King's College London, and Assistant Professor of Intelligence and Security at Leiden University. His research focuses on intelligence-propaganda interactions and international security cooperation, particularly in Cold War Southeast Asia and counter-terrorism contexts. Education: PhD in International Relations (POLIS, University of Cambridge) MPhil in International Relations (POLIS, University of Cambridge) BA (Hons) in History (Durham University) Maguire's research examines the intersection of intelligence operations and propaganda dissemination in foreign policy contexts, with specialized focus on British and American covert action in Southeast Asia. He also investigates post-colonial security relationships and international counter-terrorism cooperation frameworks. His work spans historical analysis and contemporary security challenges. Maguire's publications demonstrate interdisciplinary research across public health, virology, and immunology, particularly addressing COVID-19 diagnostics, vaccine development, and immune responses. This reflects methodological versatility in addressing complex global security and health challenges through both historical analysis and biomedical research. Scientific Awards: Lisa Smirl Prize for best thesis (University of Cambridge) Maguire leads the Dutch Government-funded 'Sharing Secrets' project investigating intelligence disclosure decision-making. He teaches intelligence studies courses and co-convenes the Cambridge Intelligence Seminar. At Leiden, he coordinates undergraduate and postgraduate programs in Intelligence Studies and Crisis Management. Maguire previously served as Research Fellow at Darwin College and the Department of Politics and International Studies (University of Cambridge), and as John Garnett Visiting Fellow at the Royal United Services Institute focusing on East African security challenges.
Akhil Khosla, MD is an Assistant Professor in the Pulmonary, Critical Care & Sleep Medicine department at Yale School of Medicine. He serves as Director of the Pulmonary Embolism Response Team (PERT) and leads resuscitation programs at Yale New Haven Health System. His expertise spans critical care medicine, pulmonary vascular disease, and emergency respiratory conditions. Dr. Khosla’s research focuses on acute cardiovascular emergencies including pulmonary embolism management, post-cardiac arrest care, and temperature control strategies. He has authored over 20 peer-reviewed publications and contributes to clinical trials evaluating outcomes in critical care patients. Key roles include: Director, PERT Program Chair, Cardiac Arrest & Rapid Response Committee Member, American College of Chest Physicians & American Thoracic Society He completed residency and fellowship training at Norwalk Hospital and Yale School of Medicine, specializing in pulmonary and critical care medicine.
Christopher G. Tarolli, MD is an Associate Professor in the Department of Neurology at the University of Rochester School of Medicine and Dentistry. He specializes in movement disorders, particularly Parkinson's disease and Huntington's disease, and serves as Director of the Mind, Brain, Behavior neuroscience course and Associate Program Director of the Adult Neurology Residency Program. His work bridges clinical practice with research in wearable sensor technology, palliative care, and health professions education. MD from SUNY Downstate College of Medicine (2012) Residency & Fellowship at University of Rochester Medical Center (2012-2018) Masters of Science in Health Professions Education (Warner School, UR) Dr. Tarolli's research focuses on novel technologies for neurological assessment, practice-based research in movement disorders, and palliative care models. He has contributed to studies on wearable sensors, remote video-based clinical trials, and symptom burden analysis in Parkinson's and Huntington disease. His work emphasizes patient-centered care and digital health innovation. Recent publications highlight his expertise in: Wearable sensor validation for neurodegenerative diseases Telemedicine applications in Parkinson's disease Palliative care integration across disease trajectories Smartphone-based Huntington's disease monitoring Machine learning for movement disorder severity quantification Quality measures in Parkinson's care Awards include the Herbert W. Mapstone Prize for Excellence in Second Year Teaching and participation in the American Academy of Neurology Emerging Leaders Program. Dr. Tarolli also leads clinical research initiatives and educational programs at the University of Rochester Medical Center.
Kelly Askew is a Professor of Anthropology and Afroamerican & African Studies at the University of Michigan’s College of Literature, Science, and the Arts. She holds a PhD in Anthropology (Harvard, 1997) and a BA in Music and Anthropology (Yale, 1997), with over three decades of fieldwork in Tanzania and Kenya. Education PhD in Anthropology, Harvard University (1997) BA in Music and Anthropology, Yale University Key Roles Chair of the Department of Anthropology Niara Sudarkasa Collegiate Professor Her research bridges three primary domains: Postsocialist transitions (e.g., property rights formalization and land conflicts), art and political aesthetics (e.g., Swahili music, African visual arts, ethnographic filmmaking), and indigenous political movements (e.g., Maasai and Parakuyo pastoralists). She has produced award-winning documentaries like The Chairman and the Lions (2013) and Maasai Remix (2019), which examine cultural resilience and land rights. Scientific awards include being a finalist for the African Studies Association Herskovits Award (2002). Recent publications analyze land dispossession mechanisms, postsocialist cultural production, and media’s role in political identity. She has secured grants from the National Science Foundation, National Endowment for the Humanities, and Ford Foundation.
Dr. Joseph Choi is a Clinical Lecturer and General Surgery Fellow at the University of Sydney's Westmead Clinical School, within the Discipline of Surgery under the Faculty of Medicine and Health. He holds academic qualifications including BSc(Adv), MBBS, MPhil, and FRACS. His clinical and research interests focus on surgical outcomes, colorectal surgery, endometriosis management, and minimally invasive techniques. Dr. Choi's research emphasizes surgical complications, anastomotic leak prediction, and emerging surgical technologies. He has contributed to over 30 peer-reviewed publications since 2011, with recent work addressing robotic surgery feasibility, Strongyloides stercoralis infections, and HER2 therapy outcomes in breast cancer. His academic profile includes collaborations with multidisciplinary teams across oncology, gastroenterology, and gynecology. No formal awards or grants are explicitly listed, though his prolific publication record reflects sustained scholarly activity.
